Earlier this year, publicly traded cannabis investment company Cronos Group became the first pot stock to uplist from the over-the-counter exchange to the Nasdaq. Within the next two months, GW Pharmaceuticals (NASDAQ:GWPH) could become the very first cannabinoid-based drug developer to get ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment